Filing Flows › Allarity Therapeutics (ALLR) › Stock forecast & fair value
Allarity Therapeutics (ALLR) stock forecast and price target
Allarity Therapeutics (ALLR) trades at $0.96. One analyst's price target is $11.00 (11×).
Allarity Therapeutics' latest quarter
Allarity Therapeutics, Q1 2026: revenue $25K, net loss $2.8M, operating cash flow −$4.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for ALLR stock?
One analyst's 12-month target is $11.00, 11× from $0.96. The average rating is none.
Does Allarity Therapeutics usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is ALLR stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.